FDA NDC Directory · JSON-LD · Markdown

Oxybutynin Chloride Extended Release

NDC 42291-635 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Generic nameOxybutynin Chloride
Labeler / ManufacturerAvKARE
Marketing categoryAbbreviated NDA (generic) · App ANDA078503
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsOXYBUTYNIN CHLORIDE (15 mg/1)
Marketing started20160309
Package count1

External sources

Source: openFDA. Public-domain (CC0).